Genetic polymorphisms in antioxidant enzymes modulate hepatic iron accumulation and hepatocellular carcinoma development in patients with alcohol-induced cirrhosis

Cancer Research

Volumn 66, Issue 5, 2006, Pages 2844-2852

  Sutton, Angela ^a,b   Nahon, Pierre ^a,b   Pessayre, Dominique ^c   Rufat, Pierre ^d   Poiré, Aurélie ^a   Ziol, Marianne ^a,b   Vidaud, Dominique ^e   Barget, Nathalie ^b   Ganne Carrié, Nathalie ^a,b   Charnaux, Nathalie ^a,b   Trinchet, Jean Claude ^a,b   Gattegno, Liliane ^a,b   Beaugrand, Michel ^a,b  

^a UNIVERSITÉ PARIS 13   (France)

^b HÔPITAL JEAN VERDIER   (France)

^c INSERM   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ALCOHOL; ANTIOXIDANT; GLUTATHIONE PEROXIDASE 1; HYDROGEN PEROXIDE; IRON; LEUCINE; MANGANESE SUPEROXIDE DISMUTASE; PROLINE; VALINE;

ADULT; ALCOHOL LIVER CIRRHOSIS; ALLELE; AMINO ACID SEQUENCE; ARTICLE; CANCER RISK; CHI SQUARE TEST; ENZYME ACTIVITY; FEMALE; FOLLOW UP; FRANCE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEQUENCE ANALYSIS;

ALLELES; CARCINOMA, HEPATOCELLULAR; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; IRON; LIVER; LIVER CIRRHOSIS, ALCOHOLIC; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; SUPEROXIDE DISMUTASE;

EID: 33645052709     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-2566     Document Type: Article

References (47)

1. Llovet JM, Beaugrand M. Hepatocellular carcinoma: present status and future prospects. J Hepatol 2003;38: S136-49.
2. Kukielka E, Dicker E, Cederbaum AI. Increased production of reactive oxygen species by rat liver mitochondria after chronic ethanol treatment. Arch Biochem Biophys 1994;309:377-86.
3. Kukielka E, Cederbaum AI. NADH-dependent microsomal interaction with ferric complexes and production of reactive oxygen intermediates. Arch Biochem Biophys 1989;275:540-50.
4. Fromenty B, Grimbert S, Mansouri A, et al. Hepatic mitochondrial DNA deletion in alcoholics: association with microvesicular steatosis. Gastroenterology 1995; 108:193-200.
5. Mansouri A, Gaou I, de Kerguenec C, et al. An alcoholic binge causes massive degradation of hepatic mitochondrial DNA in mice. Gastroenterology 1999;117:181-90.
6. McClain CJ, Barve S, Deaciuc I, et al. Cytokines in alcoholic liver disease. Semin Liver Dis 1999;19:205-19.
7. Galle PR, Hofmann, WJ, Walczak H, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995;182:1223-30.
8. Natori S, Rust C, Stadheim LM, et al. Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis. J Hepatol 2001;34:248-53.
9. Ziol M, Tepper M, Lohez M, et al. Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis. J Hepatol 2001;34:254-60.
10. Canbay A, Taimr P, Torok N, et al. Apoptotic body engulfment by a human stellate cell line is profibrogenic. Lab Invest 2003;83:655-63.
11. Ballardini G, Groff P, Zoli M, et al. Increased risk of hepatocellular carcinoma development in patients with cirrhosis and with high hepatocellular proliferation. J Hepatol 1994;20:218-22.
12. Wallace DC. Mitochondrial diseases in man and mouse. Science 1999;283:1482-8.
13. Esworthy RS, Ho YS, Chu FF. The Gpx1 gene encodes mitochondrial glutathione peroxidase in the mouse liver. Arch Biochem Biophys 1997;340:59-63.
14. Arthur JR. The glutathione peroxidases. Cell Mol Life Sci 2000;57:1825-35.
15. Low SC, Berry MJ. Knowing when not to stop: selenocysteine incorporation in eukaryotes. Trends Biochem Sci 1996;21:203-8.
16. Bermano G, Arthur JR, Hesketh JE. Role of the 3′ untranslated region in the regulation of cytosolic glutathione peroxidase and phospholipid-hydroperoxide glutathione peroxidase gene expression by selenium supply. Biochem J 1996;320:891-5.
17. Ratnasinghe D, Tangrea JA, Andersen MR, et al. Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk. Cancer Res 2000;60:6381-3.
18. Kote-Jarai Z, Durocher F, Edwards SM, et al. Association between the GCG polymorphism of the selenium-dependent GPX1 gene and the risk of young onset prostate cancer. Prostate Cancer Prostatic Dis 2002;5:189-92.
19. Hu Y, Diamond AM. Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res 2003;63:3347-51.
20. Hu YJ, Dolan ME, Bae R, et al. Allelic loss at the GPx-1 locus in cancer of head and neck. Biol Trace Elem Res 2004;101:97-106.
21. Xu Y, Kiningham KK, Devalaraja MN, et al. An intronic NF-kappaB element is essential for induction of the human manganese superoxide dismutase gene by tumor necrosis factor-alpha and interleukin-1beta. DNA Cell Biol 1999;18:709-22.
22. Koch OR, De Leo ME, Borrello S, et al. Ethanol treatment up-regulates the expression of mitochondrial manganese superoxide dismutase in rat liver. Biochem Biophys Res Commun 1994;201:1356-65.
23. Perera CS, St Clair DK, McClain CJ. Differential regulation of manganese superoxide dismutase activity by alcohol and TNF in human hepatoma cells. Arch Biochem Biophys 1995;323:471-6.
24. Sutton A, Khoury H, Prip-Buus C, et al. The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics 2003;13:145-57.
25. Sutton A, Imbert A, Igoudjil A, et al. The manganese superoxide dismutase (MnSOD) AlaloVal dimorphism modulates both mitochondrial import and mRNA stability. Pharmacogenet Genomics 2005; 15:311-9.
26. Degoul F, Sutton A, Mansouri A, et al. Homozygosity for alanine in the mitochondrial targeting sequence of superoxide dismutase and risk for severe alcoholic liver disease. Gastroenterology 2001;120:1468-74.
27. Nahon P, Sutton A, Pessayre D, et al. Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma and death. Clin Gastroenterol Hepatol 2005;3:292-8.
28. Wiseman H, Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 1996;313:17-29.
29. 2 on the expression and function of iron-responsive element-containing mRNAs in B6 fibroblasts. J Biol Chem 2001;276:19738-45.
30. Mueller S, Pantopoulos K, Hübner CA, et al. IRP1 activation by extracellular oxidative stress in the perfused rat liver. J Biol Chem 2001;276:23192-6.
31. Ganne-Carrie N, Christidis C, Chastang C, et al. Liver iron is predictive of death in alcoholic cirrhosis: a multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow up study. Gut 2000;46:277-82.
32. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
33. Nielsen P, Carpinteiro S, Fischer R, et al. Prevalence of the C282Y and H63D mutations in the HFE gene in patients with hereditary haemochromatosis and in control subjects from Northern Germany. Br J Haematol 1998;103:842-5.
34. 2- microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci U S A 1997;94:12384-9.
35. Waheed A, Grubb JH, Zhou XY, et al. Regulation of transferrin-mediated iron uptake by HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci U S A 2002;99:3117-22.
36. Ugozzoli LA, Chinn D, Hamby K. Fluorescent multicolor multiplex homogeneous assay for the simultaneous analysis of the two most common hemochromatosis mutations. Anal Biochem 2002;307:47-53.
37. Deugnier YM, Turlin B, Powell LW, et al. Differentiation between heterozygotes and homozygotes in genetic hemochromatosis by means of a histological hepatic iron index: a study of 192 cases. Hepatology 1993; 17:30-4.
38. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
39. Cox D. Regression models and life tables (with discussion). J R Stat Soc 1972;34:187-220.
40. Stewart SF, Leathart JB, Chen Y, et al. Valine-alanine manganese superoxide dismutase polymorphism is not associated with alcohol-induced oxidative stress or liver fibrosis. Hepatology 2002;36:1355-60.
41. Brind A, Fryer A, Hurlstone A, et al. The role in polymorphism in manganese superoxide dismutase in susceptibility to alcoholic liver disease. Gastroenterology 2003;124:2000-2.
42. Fernandez-Checa JC, Garcia-Ruiz C, Ookhtens M, et al. Impaired uptake of glutathione by hepatic mitochondria from chronic ethanol-fed rats. Tracer kinetic studies in vitro and in vivo and susceptibility to oxidant stress. J Clin Invest 1991;87:397-405.
43. Polavarapu R, Spitz DR, Sim JE, et al. Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil. Hepatology 1998;27:1317-23.
44. Suzuki Y, Saito H, Suzuki M, et al. Up-regulation of transferrin receptor expression in hepatocytes by habitual alcohol drinking is implicated in hepatic iron overload in alcoholic liver disease. Alcohol Clin Exp Res 2002;26:26-318.
45. Pessayre D, Fromenty B, Mansouri A. Mitochondrial injury in steatohepatitis. Eur J Gastroenterol Hepatol 2004;16:1095-105.
46. Burdon RH, Gill V, Rice-Evans C. Cell proliferation and oxidative stress. Free Radic Res Commun 1989;7:149-59.
47. Ambrosone CB, Freudenheim JL, Thompson PA, et al. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res 1999;59:602-6.